This Drug Cut LDL 56%—But That Wasn’t the Goal

Check out the long-form video: https://youtu.be/5idzP5ghT7A Ezetimibe is typically seen as a cholesterol-lowering drug that works in the gut—but emerging evidence suggests it may also act in the brain. By interfering with a protein interaction linked to misfolding, it could play a role in processes relevant to neurodegeneration. Some data even show a lower risk of Alzheimer’s disease among users, though the evidence is still evolving. For the full mechanisms, limitations, and nuance, watch the long-form video. #Ezetimibe #Cholesterol #LDL #Neurodegeneration #AlzheimersResearch #BrainHealth #StayCurious